Autolus Therapeutics plc (AUTL)
NASDAQ·Healthcare·Biotechnology
$1.48
+3.87%
Mkt Cap $431.15M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$8.87
Range $7.60 – $11.00
Implied Upside
+501.4%
Consensus $8.87 vs current $1.48
NASDAQ·Healthcare·Biotechnology
$1.48
+3.87%
Mkt Cap $431.15M
No recent rating data.
Price Target (4 analysts)
$8.87
Range $7.60 – $11.00
+501.4%
Consensus $8.87 vs current $1.48